Growth Hormone Releasing Peptide-2 (GHRP-2)
Growth Hormone Releasing Peptides or Peptides stimulating endogenous Growth Hormone secretion
Growth Hormone Releasing Peptides (GHRP-2, GHRP-6 and Hexarelin) are a small family of peptides acting at the pituitary and the hypothalamus to release Growth hormone (GH). These peptides were discovered 20 years ago and in clinical researches proved to be able to stimulate pituitary to produce endogenous Growth hormone.
GHRP-2, GHRP-6 and Hexarelin are replaceable drugs and have similar mechanism of action.
Hexarelin is considered to be the strongest peptide stimulating GH secretion. With its use, the increase in cortisol and prolactin levels is also high enough. GHRP-2 is less strong than Hexarelin, but the increase in cortisol and prolactin levels is less too. GHRP-6 is less strong than GHRP-2, but when used in dosage up to 100mcg, it has no influence on the levels of cortisol and prolactin, and in dosage more than 100mcg, the increase in cortisol and prolactin levels is modest.
Another drug stimulating endogenous GH secretion is long-acting CJC-1295 (Long-acting Growth Hormone Releasing Hormone Analog).
Common dosage regimen of Peptides:
Cycle: 16 months. The dosage is prescribed individually and injected 1-6 times a day starting with 25-50mcg and gradually increasing it with the step of 25-50mcg to achieve minimal side effects. Then, there should be return to the starting dose. The injections are usually made subcutaneously in an abdominal area 30 minutes before or in 1-1.5 after meal. The time between injections should be 3-4 hours (in order the body has the time to produce GH for further release).
Growth Hormone Releasing Peptide-2 (GHRP-2)
Growth Hormone Releasing Peptide-2 (GHRP-2) is a peptide made up of just six amino acids, which stimulates secretion of endogenous GH. In researches, GHRP-2 showed ability to stimulate the pituitary to increase secretion of GH by 7-15 times, to stimulate ghrelin receptors and in such a way to promote appetite.
According to the results of clinical trial, which were published in The Endocrinology and Metabolism Magazine in 1997, GHRP-2 increases GH secretion both in adults and children, and even in elders.
The main effects of GHRP-2 are GH secretion stimulation, appetite promotion, fat mass decrease and muscle mass increase, lowering of cholesterol level, skin and bones state improving, defense of the liver and anti-inflammatory action.
The researches confirmed high safety of GHRP-2 and almost no side effects, if GHRP-2 is administered within the recommended dose range. GHRP-2 has been clinically trialed for 30 years. Thus, delayed side effects can be excluded.
Insulin-Like Growth Factor-1 Lr3
IGF-1 is a polypeptide hormone that has the same some of the same molecular properties as insulin. IGF dose actually stand for insulin-like growth factor. IGF-1 is mainly responsible for muscle growth and repair of adults. Long R3 IGF-1 is a more potent version of IGF-1. It’s chemically altered or “enhanced” to prevent deactivation by IGF-1 binding proteins in the bloodstream resulting in a longer half-life of 20-30 hours. IGF-1 Lr3 Unlike the above mentions peptide compounds, is not just a Growth Hormone secretatogue like ghrp-6, hexarelin or cjc-1295 but rather IGF-1 lr3 is a hormone in and of itself!! IGF-1 is the main and most beneficial Growth Factor the HGH breaks down or converts into. Many Human Growth Hormone Users have discovered it is much cheaper, and a whole lot faster to feel the effects of IGF-1 lr3, and have begun to replace their HGH with IGF-1 lr3.The anaology is why drink tons of mouth wash to get drunk when you can just buy a beer, or why take an oral testosterone booster when you can just inject real testosterone, yes the first anaology is a stretch but you get the point beings IGF-1 lr3 is the main beneficial byproduct of Human Growth Hormone Injections.
Growth Hormone Releasing Peptides or Peptides stimulating endogenous Growth Hormone secretion
Growth Hormone Releasing Peptides (GHRP-2, GHRP-6 and Hexarelin) are a small family of peptides acting at the pituitary and the hypothalamus to release Growth hormone (GH). These peptides were discovered 20 years ago and in clinical researches proved to be able to stimulate pituitary to produce endogenous Growth hormone.
GHRP-2, GHRP-6 and Hexarelin are replaceable drugs and have similar mechanism of action.
Hexarelin is considered to be the strongest peptide stimulating GH secretion. With its use, the increase in cortisol and prolactin levels is also high enough. GHRP-2 is less strong than Hexarelin, but the increase in cortisol and prolactin levels is less too. GHRP-6 is less strong than GHRP-2, but when used in dosage up to 100mcg, it has no influence on the levels of cortisol and prolactin, and in dosage more than 100mcg, the increase in cortisol and prolactin levels is modest.
Another drug stimulating endogenous GH secretion is long-acting CJC-1295 (Long-acting Growth Hormone Releasing Hormone Analog).
Common dosage regimen of Peptides:
Cycle: 16 months. The dosage is prescribed individually and injected 1-6 times a day starting with 25-50mcg and gradually increasing it with the step of 25-50mcg to achieve minimal side effects. Then, there should be return to the starting dose. The injections are usually made subcutaneously in an abdominal area 30 minutes before or in 1-1.5 after meal. The time between injections should be 3-4 hours (in order the body has the time to produce GH for further release).
Growth Hormone Releasing Peptide-2 (GHRP-2)
Growth Hormone Releasing Peptide-2 (GHRP-2) is a peptide made up of just six amino acids, which stimulates secretion of endogenous GH. In researches, GHRP-2 showed ability to stimulate the pituitary to increase secretion of GH by 7-15 times, to stimulate ghrelin receptors and in such a way to promote appetite.
According to the results of clinical trial, which were published in The Endocrinology and Metabolism Magazine in 1997, GHRP-2 increases GH secretion both in adults and children, and even in elders.
The main effects of GHRP-2 are GH secretion stimulation, appetite promotion, fat mass decrease and muscle mass increase, lowering of cholesterol level, skin and bones state improving, defense of the liver and anti-inflammatory action.
The researches confirmed high safety of GHRP-2 and almost no side effects, if GHRP-2 is administered within the recommended dose range. GHRP-2 has been clinically trialed for 30 years. Thus, delayed side effects can be excluded.
Insulin-Like Growth Factor-1 Lr3
IGF-1 is a polypeptide hormone that has the same some of the same molecular properties as insulin. IGF dose actually stand for insulin-like growth factor. IGF-1 is mainly responsible for muscle growth and repair of adults. Long R3 IGF-1 is a more potent version of IGF-1. It’s chemically altered or “enhanced” to prevent deactivation by IGF-1 binding proteins in the bloodstream resulting in a longer half-life of 20-30 hours. IGF-1 Lr3 Unlike the above mentions peptide compounds, is not just a Growth Hormone secretatogue like ghrp-6, hexarelin or cjc-1295 but rather IGF-1 lr3 is a hormone in and of itself!! IGF-1 is the main and most beneficial Growth Factor the HGH breaks down or converts into. Many Human Growth Hormone Users have discovered it is much cheaper, and a whole lot faster to feel the effects of IGF-1 lr3, and have begun to replace their HGH with IGF-1 lr3.The anaology is why drink tons of mouth wash to get drunk when you can just buy a beer, or why take an oral testosterone booster when you can just inject real testosterone, yes the first anaology is a stretch but you get the point beings IGF-1 lr3 is the main beneficial byproduct of Human Growth Hormone Injections.
Last edited:
